This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Revvity Launches Signals AI to Advance Scientific R&D Workflows
by Urbi Guha
RVTY expands AI capabilities in Signals software with Signals AI, designed to help scientists turn connected R&D data into actionable insights.
ISRGNegative Net Change WSTNegative Net Change GMEDNegative Net Change RVTYNegative Net Change
medical medical-devices
Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?
by Zacks Equity Research
DGX gains from Advanced Diagnostics, physician and consumer testing growth, plus AI-driven efficiency efforts, even as debt and policy risks linger.
DGXNegative Net Change ALGNNegative Net Change IARTNegative Net Change GMEDNegative Net Change
medical medical-devices
INSP Highlights New OSA Data and PREDICTOR Study at SLEEP 2026
by Zacks Equity Research
Inspire Medical's SLEEP 2026 updates spotlight new Inspire V data, remote patient tools and research supporting wider OSA therapy adoption.
WSTNegative Net Change GMEDNegative Net Change INSPPositive Net Change BDSXNegative Net Change
medical medical-devices
3 Medical Stocks to Bet on Amid Market Optimism Following SpaceX IPO
by Indrajit Bandyopadhyay
Medical stocks like Centene, DaVita and BrightSpring could rally as SpaceX IPO-fueled market optimism lifts broader sector sentiment.
DVANegative Net Change CNCPositive Net Change GOOGLPositive Net Change SPCXNegative Net Change BTSGNegative Net Change
medical medical-devices
Affirm Holdings (AFRM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
AFRMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
How to Approach Abbott Stock Following Its Sharp YTD Decline?
by Moumi Mondal
ABT falls 29.4% YTD as respiratory testing weakness, China uncertainty and acquisition dilution pressure results and outlook.
ABTPositive Net Change LHNegative Net Change BDXPositive Net Change
medical medical-devices
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform
by Zacks Equity Research
BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.
BAXPositive Net Change WSTNegative Net Change GMEDNegative Net Change BDSXNegative Net Change
medical medical-devices
10x Genomics, Cleveland Clinic Team Up on Bladder Cancer Diagnostics
by Zacks Equity Research
TXG collaborates with the Cleveland Clinic to advance bladder cancer diagnostics using Flex Apex, Xenium and potentially Atera.
ISRGNegative Net Change WSTNegative Net Change GMEDNegative Net Change TXGNegative Net Change
medical medical-devices
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?
by Zacks Equity Research
Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.
CAHPositive Net Change MCKPositive Net Change CORPositive Net Change WSTNegative Net Change
medical medical-devices
NVST Stock Rallies 37.1% in a Year: What's Behind the Drive?
by Zacks Equity Research
Envista rises 37.1% in a year as new dental product launches, margin gains, acquisitions and a strong balance sheet fuel growth.
ALGNNegative Net Change IARTNegative Net Change GMEDNegative Net Change NVSTNegative Net Change
medical medical-devices